Targeting mitochondria: a novel approach for treating platinum-resistant ovarian cancer

Abstract Ovarian cancer is a prevalent gynecologic malignancy with the second-highest mortality rate among gynecologic malignancies. Platinum-based chemotherapy is the first-line treatment for ovarian cancer; however, a majority of patients with ovarian cancer experience relapse and develop platinum...

Full description

Saved in:
Bibliographic Details
Main Authors: Xin Cui, Juan Xu, Xuemei Jia
Format: Article
Language:English
Published: BMC 2024-10-01
Series:Journal of Translational Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12967-024-05770-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850202203572142080
author Xin Cui
Juan Xu
Xuemei Jia
author_facet Xin Cui
Juan Xu
Xuemei Jia
author_sort Xin Cui
collection DOAJ
description Abstract Ovarian cancer is a prevalent gynecologic malignancy with the second-highest mortality rate among gynecologic malignancies. Platinum-based chemotherapy is the first-line treatment for ovarian cancer; however, a majority of patients with ovarian cancer experience relapse and develop platinum resistance following initial treatment. Despite extensive research on the mechanisms of platinum resistance at the nuclear level, the issue of platinum resistance in ovarian cancer remains largely unresolved. It is noteworthy that mitochondrial DNA (mtDNA) exhibits higher affinity for platinum compared to nuclear DNA (nDNA). Mutations in mtDNA can modulate tumor chemosensitivity through various mechanisms, including DNA damage responses, shifts in energy metabolism, maintenance of Reactive Oxygen Species (ROS) homeostasis, and alterations in mitochondrial dynamics. Concurrently, retrograde signals produced by mtDNA mutations and their subsequent cascades establish communication with the nucleus, leading to the reorganization of the nuclear transcriptome and governing the transcription of genes and signaling pathways associated with chemoresistance. Furthermore, mitochondrial translocation among cells emerges as a crucial factor influencing the effectiveness of chemotherapy in ovarian cancer. This review aims to explore the role and mechanism of mitochondria in platinum resistance, with a specific focus on mtDNA mutations and the resulting metabolic reprogramming, ROS regulation, changes in mitochondrial dynamics, mitochondria-nucleus communication, and mitochondrial transfer. Graphical Abstract
format Article
id doaj-art-09ccba3ab5df4312bf4e8ca9a78b9b68
institution OA Journals
issn 1479-5876
language English
publishDate 2024-10-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj-art-09ccba3ab5df4312bf4e8ca9a78b9b682025-08-20T02:11:50ZengBMCJournal of Translational Medicine1479-58762024-10-0122111310.1186/s12967-024-05770-yTargeting mitochondria: a novel approach for treating platinum-resistant ovarian cancerXin Cui0Juan Xu1Xuemei Jia2Nanjing Women and Children’s Healthcare Hospital, Women’s Hospital of Nanjing Medical UniversityNanjing Women and Children’s Healthcare Hospital, Women’s Hospital of Nanjing Medical UniversityNanjing Women and Children’s Healthcare Hospital, Women’s Hospital of Nanjing Medical UniversityAbstract Ovarian cancer is a prevalent gynecologic malignancy with the second-highest mortality rate among gynecologic malignancies. Platinum-based chemotherapy is the first-line treatment for ovarian cancer; however, a majority of patients with ovarian cancer experience relapse and develop platinum resistance following initial treatment. Despite extensive research on the mechanisms of platinum resistance at the nuclear level, the issue of platinum resistance in ovarian cancer remains largely unresolved. It is noteworthy that mitochondrial DNA (mtDNA) exhibits higher affinity for platinum compared to nuclear DNA (nDNA). Mutations in mtDNA can modulate tumor chemosensitivity through various mechanisms, including DNA damage responses, shifts in energy metabolism, maintenance of Reactive Oxygen Species (ROS) homeostasis, and alterations in mitochondrial dynamics. Concurrently, retrograde signals produced by mtDNA mutations and their subsequent cascades establish communication with the nucleus, leading to the reorganization of the nuclear transcriptome and governing the transcription of genes and signaling pathways associated with chemoresistance. Furthermore, mitochondrial translocation among cells emerges as a crucial factor influencing the effectiveness of chemotherapy in ovarian cancer. This review aims to explore the role and mechanism of mitochondria in platinum resistance, with a specific focus on mtDNA mutations and the resulting metabolic reprogramming, ROS regulation, changes in mitochondrial dynamics, mitochondria-nucleus communication, and mitochondrial transfer. Graphical Abstracthttps://doi.org/10.1186/s12967-024-05770-yMitochondriaPlatinum resistanceMitochondria DNA (mtDNA)Metabolic reprogrammingMitochondrial dynamicsMitochondria-nucleus communication
spellingShingle Xin Cui
Juan Xu
Xuemei Jia
Targeting mitochondria: a novel approach for treating platinum-resistant ovarian cancer
Journal of Translational Medicine
Mitochondria
Platinum resistance
Mitochondria DNA (mtDNA)
Metabolic reprogramming
Mitochondrial dynamics
Mitochondria-nucleus communication
title Targeting mitochondria: a novel approach for treating platinum-resistant ovarian cancer
title_full Targeting mitochondria: a novel approach for treating platinum-resistant ovarian cancer
title_fullStr Targeting mitochondria: a novel approach for treating platinum-resistant ovarian cancer
title_full_unstemmed Targeting mitochondria: a novel approach for treating platinum-resistant ovarian cancer
title_short Targeting mitochondria: a novel approach for treating platinum-resistant ovarian cancer
title_sort targeting mitochondria a novel approach for treating platinum resistant ovarian cancer
topic Mitochondria
Platinum resistance
Mitochondria DNA (mtDNA)
Metabolic reprogramming
Mitochondrial dynamics
Mitochondria-nucleus communication
url https://doi.org/10.1186/s12967-024-05770-y
work_keys_str_mv AT xincui targetingmitochondriaanovelapproachfortreatingplatinumresistantovariancancer
AT juanxu targetingmitochondriaanovelapproachfortreatingplatinumresistantovariancancer
AT xuemeijia targetingmitochondriaanovelapproachfortreatingplatinumresistantovariancancer